PENN Medicine in the News

Father of Cognitive Therapy, Aaron T. Beck, MD, Wins International Lifetime Achievement Award
19 Nov 2009
Aaron Temkin Beck, MD, the father of Cognitive Therapy, has been presented with the Anna-Monika Prize, awarded once every two years by the Anna-Monika Foundation, for advancing knowledge of the biological structure and functional disturbances of depression. The privately funded Anna-Monika Foundation, established in 1964 and based in Berlin, Germany, promotes experimental research on the causes of depression.

Antioxidant Found in Vegetables has Implications for Treating Cystic Fibrosis
16 Nov 2009
Scientists at the University of Pennsylvania School of Medicine discovered that a dietary antioxidant found in such vegetables as broccoli and cauliflower protects cells from damage caused by chemicals generated during the body’s inflammatory response to infection and injury. The finding has implications for such inflammation-based disorders as cystic fibrosis (CF), diabetes, heart disease, and neurodegeneration.

Penn Study Provides First Clear Idea of How Rare Bone Disease Progresses
12 Nov 2009
An international team of scientists, led by researchers at the University of Pennsylvania School of Medicine, is taking the first step in developing a treatment for a rare genetic disorder called fibrodysplasia ossificans progressiva (FOP), in which the body’s skeletal muscles and soft connective tissue turns to bone, immobilizing patients over a lifetime with a second skeleton. Their latest study provides the first clear glimpse of how FOP might develop at a cellular level in the human body.

David A. Asch, MD, MBA Receives AAMC Distinguished Teacher Award
10 Nov 2009
David A. Asch, MD, MBA, the Robert D. Eilers Professor of Medicine and Health Care Management and Economics at the University of Pennsylvania School of Medicine and the Wharton School, was presented with the Alpha Omega Alpha Robert J. Glaser Distinguished Teacher Award by the Association American of Medical Colleges (AAMC).

Higher Carotid Arterial Stenting Rates Associated with Poorer Clinical Outcomes
6 Nov 2009
Among eligible Medicare beneficiaries, increased use of carotid arterial stenting (CAS) procedures to treat carotid stenosis—the narrowing of the carotid artery—is associated with higher rates of mortality and adverse clinical outcomes, including heart attack and stroke, according to researchers from the University of Pennsylvania School of Medicine.

More News...